MRHB Awarded ‘Best New Islamic Crypto Platform’, Incubated by International Incubation Center of ICYF in Istanbul, Türkiye
31 janv. 2023 03h16 HE
|
MRHB.Network
MELBOURNE, Australia, Jan. 31, 2023 (GLOBE NEWSWIRE) -- MRHB, the world’s first halal decentralized finance (DeFi) ecosystem, has recently bagged two awards from Singapore-based World Business...
Meet the Real Superheroes at Orthopaedic Institute for Children “STAND for KIDS” Gala
06 juin 2022 12h30 HE
|
Stand for Kids
~Patients And Doctors Celebrated in Emotion-Packed Performance~JULIE BOWEN, GARY COLE, JON HUERTAS plus more…CHRISTOPHER GORHAM, “THE LINCOLN LAWYER,” emceeJonnie Davis, President of ABC Signature...
RedHill Biopharma Adds Israel Rights to Movantik® From AstraZeneca
08 oct. 2020 10h30 HE
|
RedHill Biopharma Ltd.
RedHill obtains Israel rights to Movantik® from AstraZeneca, giving RedHill global rights, excluding Europe and Canada--Movantik approved for opioid-induced constipation in Israel under the brand name...
RedHill Biopharma Announces New Agreement with Daiichi Sankyo for Movantik®
03 août 2020 07h00 HE
|
RedHill Biopharma Ltd.
RedHill acquired Movantik® for opioid induced constipation from AstraZeneca in April 2020; Movantik® generated $96 million in 2019 --RedHill and Daiichi Sankyo replaced their co-commercialization...
BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28 août 2019 07h45 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic...
BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA®
09 juil. 2019 08h00 HE
|
BioDelivery Sciences International, Inc.
Regional Commercial Plans Improved Access for More Than 6 Million Lives During 2Q More Than 90% of Commercial Lives Now Have Access to BELBUCA in the U.S. RALEIGH, N.C., July 09, 2019 (GLOBE...
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
10 avr. 2019 16h06 HE
|
BioDelivery Sciences International, Inc.
Long-term revenue potential of over $75 million for NME with IP protection through 2031 Leverages existing commercial capabilities to provide a novel treatment option for OIC ...
Sucampo Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote
12 juin 2014 14h41 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., June 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today issued the following statement regarding the...
Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal
06 mai 2014 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, announced that its recent study, "A Randomized Study of...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences
01 mai 2014 06h45 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...